Abstract
Holt–Oram syndrome (HOS) is a rare disorder characterized by cardiac and upper-limb defects. Pathogenic variants in TBX5—a gene encoding a transcription factor important for heart and skeletal development—are the only known cause of HOS. Here, we present the identification and functional analysis of two novel TBX5 pathogenic variants found in two individuals with HOS presenting distinct phenotypes. The individual with the c.905delA variant has a severe cardiac phenotype but mild skeletal defects, unlike the individual with the c.246_249delGATG variant who has no cardiac problems but severe upper limbs malformations, including phocomelia. Both frameshift variants, c.246_249delGATG and c.905delA, generate mRNAs harbouring premature stop codons which, if not degraded by nonsense mediated decay, will lead to the production of shorter TBX5 proteins, p.Gln302Argfs*92 and p.Met83Phefs*6, respectively. Immunocytochemistry results suggest that both mutated proteins are produced and furthermore, like the wild-type protein, p.Gln302Argfs*92 mutant appears to be mainly localized in the nucleus, in contrast with p.Met83Phefs*6 mutant that displays a higher level of cytoplasmic localization. In addition, luciferase activity analysis revealed that none of the TBX5 mutants are capable of transactivating the NPPA promoter. In conclusion, our results provide evidence that both pathogenic variants cause a severe TBX5 loss-of-function, dramatically reducing its biological activity. The absence of cardiac problems in the individual with the p.Met83Phefs*6 variant supports the existence of other mechanisms/genes underlying the pathogenesis of HOS and/or the existence of an age-related delay in the development of a more serious cardiac phenotype. Further studies are required to understand the differential effects observed in the phenotypes of both individuals.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahmed JN, Ali RG, Warr N, Wilson HM, Bellchambers HM, Barratt KS, Thompson AJ, Arkell RM (2013) A murine Zic3 transcript with a premature termination codon evades nonsense-mediated decay during axis formation. DMM Dis Model Mech 6:755–767. https://doi.org/10.1242/dmm.011668
Al-Qattan MM, Abou Al-Shaar H (2015) Molecular basis of the clinical features of Holt–Oram syndrome resulting from missense and extended protein mutations of the TBX5 gene as well as TBX5 intragenic duplications. Gene 560:129–136. https://doi.org/10.1016/j.gene.2015.02.017
Aoki H, Horie M (2018) Electrical disorders in atrial septal defect: genetics and heritability. J Thorac Dis 10:S2848–S2853. https://doi.org/10.21037/jtd.2018.02.53
Asselta R, Duga S, Spena S, Santagostino E, Peyvandi F, Piseddu G, Targhetta R, Malcovati M, Mannucci PO, Tenchini ML (2001) Congenital afibrinogenemia: mutations leading to premature termination codons in fibrinogen Aα-chain gene are not associated with the decay of the mutant mRNAs. Blood 98:3685–3692. https://doi.org/10.1182/blood.V98.13.3685
Atik T, Dervisoglu H, Onay H, Ozkinay F, Cogulu O (2018) A new mutation in the TBX5 gene in Holt-Oram syndrome: two cases in the same family and prenatal diagnosis. Jounal Trop Pediatr 60:257–259. https://doi.org/10.1093/tropej/fmt109
Auerbach AD (2009) Fanconi anemia and its diagnosis. Mutat Res 668:4–10. https://doi.org/10.1016/j.mrfmmm.2009.01.013
Basson CT, Bachinsky DR, Lin RC, Levi T, Elkins JA, Soults J, Grayzel D, Kroumpouzou E, Traill TA, Leblanc-Straceski J, Renault B, Kucherlapati R, Seidman JG, Seidman CE (1997) Mutations in human cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet 15:30–35. https://doi.org/10.1038/ng0197-30
Basson CT, Huang T, Lin RC, Bachinsky DR, Weremowicz S, Vaglio A, Bruzzone R, Quadrelli R, Lerone M, Romeo G, Silengo M, Pereira A, Krieger J, Mesquita SF, Kamisago M, Morton CC, Pierpont ME, Müller CW, Seidman JG, Seidman CE (1999) Different TBX5 interactions in heart and limb defined by Holt–Oram syndrome mutations. Proc Natl Acad Sci 96:2919–2924. https://doi.org/10.1073/pnas.96.6.2919
Bateman JF, Freddi S, Nattrass G, Savarirayan R (2003) Tissue-specific RNA surveillance? Nonsense-mediated mRNA decay causes collagen X haploinsufficiency in Schmid metaphyseal chondrodysplasia cartilage. Hum Mol Genet 12:217–225. https://doi.org/10.1093/hmg/ddg054
Bimber B, Dettman RW, Simon H (2008) Differential regulation of Tbx5 protein expression and sub-cellular localization during heart development. Dev Biol 302:230–242
Böhm J, Heinritz W, Craig A, Vujic M, Ekman-joelsson M, Kohlhase J, Froster U (2008) Functional analysis of the novel TBX5 c.1333delC mutation resulting in an extended TBX5 protein. BMC Med Genet 9:88. https://doi.org/10.1186/1471-2350-9-88
Boogerd CJJ, Dooijes D, Ilgun A, Hordijk R, Van De Laar IMBH, Rump P, Veenstra-Knol HE, Moorman AFM, Barnett P, Postma AV (2010) Functional analysis of novel TBX5 T-box mutations associated with Holt–Oram syndrome. Cardiovasc Res 88:130–139. https://doi.org/10.1093/cvr/cvq178
Borozdin W, Bravo AM, Acosta F, Bamshad MJ, Botzenhart EM, Froster UG, Lemke J, Schinzel A, Spranger S, Mcgaughran J, Wand D, Chrzanowska KH, Kohlhase J (2006) Expanding the spectrum of TBX5 mutations in Holt–Oram syndrome: detection of two intragenic deletions by quantitative real time PCR, and report of eight novel point mutations. Hum Mutat 27:975–976. https://doi.org/10.1002/humu.9449
Brassington AM, Sung SS, Toydemir RM, Le T, Roeder AD, Rutherford AE, Whitby FG, Jorde LB, Bamshad MJ (2003) Expressivity of Holt–Oram syndrome is not predicted by TBX5 genotype. Am J Hum Genet 73:74–85. https://doi.org/10.1086/376436
Bruneau BG, Nemer G, Schmitt JP, Robitaille L, Caron S, Conner DA, Gessler M, Nemer M, Seidman CE, Seidman JG (2001) A murine model of Holt–Oram syndrome defines roles of the T-Box transcription factor Tbx5 in cardiogenesis and disease. Cell 106:709–721
Carmona-mora P, Canales CP, Cao L, Perez IC, Srivastava AK, Young JI, Walz K (2012) RAI1 transcription factor activity is impaired in mutants associated with Smith-Magenis syndrome. PLoS ONE 7:e45155. https://doi.org/10.1371/journal.pone.0045155
Chaldoupi S, Loh P, Hauer RNW, De BJMT, Van RHVM (2009) The role of connexin40 in atrial fibrillation. Cardiovasc Res 84:15–23. https://doi.org/10.1093/cvr/cvp203
Chin J, Pereira S, Camacho A, Pessoa B, Bento D, Pereira J, de Jesus I (2014) Holt–Oram syndrome: a case report. Rev Port Cardiol 33:737 (e 1–5)
Chun F, Mugen L, Wang Q (2012) Functional analysis of TBX5 missense mutations associated with Holt–Oram syndrome. J Biol Chem 100:130–134. https://doi.org/10.1016/j.pestbp.2011.02.012.Investigations
Collavoli A, Hatcher CJ, He J, Okin D, Deo R, Basson CT (2003) TBX5 nuclear localization is mediated by dual cooperative intramolecular signals. J Mol Cell Cardiol 35:1191–1195. https://doi.org/10.1016/S0022-2828(03)00231-1
Darwich R, Li W, Yamak A, Komati H, Andelfinger G, Sun K, Nemer M (2017) KLF13 is a genetic modifier of the Holt-Oram syndrome gene TBX5. Hum Mol Genet 26:942–954. https://doi.org/10.1093/hmg/ddx009
Debeer P, Leuven UZ, Leuven UZ, Gewillig M (2007) Novel TBX5 mutations in patients with Holt–Oram syndrome. Clin Orthop Relat Res 462:20–26. https://doi.org/10.1097/BLO.0b013e3181123ffe
Dreßen M, Lahm H, Lahm A, Wolf K, Doppler S, Deutsch M-A, Cleuziou J, Pabst von Ohain J, Schön P, Ewert P, Malcic I, Lange R, Krane M (2016) A novel de novo TBX5 mutation in a patient with Holt–Oram syndrome leading to a dramatically reduced biological function. Mol Genet Genomic Med 4:557–567. https://doi.org/10.1002/mgg3.234
Dyle MC, Kolakada D, Cortazar MA, Jagannathan S (2020) How to get away with nonsense: mechanisms and consequences of escape from nonsense-mediated RNA decay. Wiley Interdiscip Rev RNA 11:1–16. https://doi.org/10.1002/wrna.1560
Fan C, Duhgon M, Oberti C, Chen S, Hiroi Y, Komuro I (2003) Novel TBX5 mutations and molecular mechanism for Holt-Oram syndrome. J Med Genet 40:1–7. https://doi.org/10.1136/jmg.40.3.e29
Ghosh TK, Packham EA, Bonser AJ, Robinson TE, Cross SJ, Brook JD (2001) Characterization of the TBX5 binding site and analysis of mutations that cause Holt–Oram syndrome. Hum Mol Genet 10:1983–1994. https://doi.org/10.1093/hmg/10.18.1983
Govindapillai A, Hotchkiss A, Baguma-nibasheka M, Rose RA, Miquerol L, Smithies O, Maeda N, Pasumarthi KBS (2018) Characterizing the role of atrial natriuretic peptide signaling in the development of embryonic ventricular conduction system. Sci Rep 8:6939. https://doi.org/10.1038/s41598-018-25292-0
Greenhalgh KL, Howell RT, Bottani A, Ancliff PJ, Brunner HG, Verschuuren-Bemelmans CC, Vernon E, Brown KW, Newbury-Ecob RA (2002) Thrombocytopenia-absent radius syndrome: a clinical genetic study. J Med Genet 39:876–881. https://doi.org/10.1136/jmg.39.12.876
Hatcher CJ, Goldstein MM, Mah CS, Delia CS, Basson CT (2000) Identification and localization of TBX5 transcription factor during human cardiac morphogenesis. Dev Dyn 219:90–95. https://doi.org/10.1002/1097-0177(200009)219:1%3c90::AID-DVDY1033%3e3.0.CO;2-L
He J, Mcdermott DA, Song Y, Gilbert F, Kligman I, Basson CT (2004) Preimplantation genetic diagnosis of human congenital heart malformation and Holt–Oram syndrome. Am J Med Genet 126:93–98. https://doi.org/10.1002/ajmg.a.20487
Heinritz W, Moschik A, Kujat A, Spranger S, Heilbronner H, Demuth S, Bier A, Tihanyi M, Mundlos S, Gruenauer-Kloevekorn C, Froster UG (2005) Identification of new mutations in the TBX5 gene in patients with Holt–Oram syndrome. Heart 91:383–384. https://doi.org/10.1136/hrt.2004.036855
Hiroi Y, Kudoh S, Monzen K, Ikeda Y, Yazaki Y, Nagai R, Komuro I (2001) Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation. Nature 28:276–280. https://doi.org/10.1038/90123
Holt M, Oram S (1960) Familial heart disease with skeletal malformations. Br Heart J 22:236–242. https://doi.org/10.1136/hrt.22.2.236
Hoogaars WMH, Barnett P, Moorman AFM, Christoffels VM (2007) T-box factors determine cardiac design. Cell Mol Life Sci 64:646–660. https://doi.org/10.1007/s00018-007-6518-z
Huang T (2002) Current advances in Holt–Oram syndrome. Curr Opin Pediatr 14:691–695. https://doi.org/10.1097/00008480-200212000-00008
Jhang WK, Lee BH, Kim G, Lee J, Yoo H (2015) Clinical and molecular characterisation of Holt-Oram syndrome focusing on cardiac manifestations. Cardiol Young 25:1093–1098. https://doi.org/10.1017/S1047951114001656
Koshiba-Takeuchi K, Takeuchi JK, Arruda EP, Kathiriya IS, Mo R, Hui C, Srivastava D, Bruneau BG (2006) Cooperative and antagonistic interactions between Sall4 and Tbx5 pattern the mouse limb and heart. Nature 38:175–183. https://doi.org/10.1038/ng1707
Kulisz A, Simon H (2008) An evolutionarily conserved nuclear export signal facilitates cytoplasmic localization of the Tbx5 transcription factor. Mol Cell Biol 28:1553–1564. https://doi.org/10.1128/MCB.00935-07
Linde L, Boelz S, Neu-Yilik G, Kulozik AE, Kerem B (2007) The efficiency of nonsense-mediated mRNA decay is an inherent character and varies among different cells. Eur J Hum Genet 15:1156–1162. https://doi.org/10.1038/sj.ejhg.5201889
Lindeboom RGH, Supek F, Lehner B (2016) The rules and impact of nonsense-mediated mRNA decay in human cancers. Nat Genet 48:1112–1118. https://doi.org/10.1038/ng.3664
Mcdermott DA, Bressan MC, He JIE, Lee JS, Aftimos S, Brueckner M, Gilbert F, Graham GE, Hannibal MC, Innis JW, Pierpont ME, Raas-rothschild A, Shanske AL, Smith WE, Spencer RH, John-sutton MGST, Maldergem LVAN, Waggoner DJ, Weber M, Basson CT (2005) TBX5 genetic testing validates strict clinical criteria for Holt-Oram syndrome. Pediatr Res 58:981–986. https://doi.org/10.1203/01.PDR.0000182593.95441.64
Mori AD, Bruneau BG (2004) TBX5 mutations and congenital heart disease: Holt–Oram syndrome revealed. Curr Opin Cardiol 19:211–215. https://doi.org/10.1097/00001573-200405000-00004
Moskowitz IPG, Pizard A, Patel VV, Bruneau BG, Kim JB, Kupershmidt S, Roden D, Berul CI, Seidman CE, Seidman JG (2004) The T-Box transcription factor Tbx5 is required for the patterning and maturation of the murine cardiac conduction system. Development 131:4107–4116. https://doi.org/10.1242/dev.01265
Moskowitz IPG, Kim JB, Moore ML, Wolf CM, Peterson MA, Shendure J, Nobrega MA, Yokota Y, Berul C, Izumo S, Seidman JG (2007) A molecular pathway including Id2, Tbx5, and Nkx2-5 required for cardiac conduction system development. Cell 129:1365–1376. https://doi.org/10.1016/j.cell.2007.04.036
Nadeau M, Georges RO, Laforest B, Yamak A, Lefebvre C (2010) An endocardial pathway involving Tbx5, Gata4, and Nos3 required for atrial septum formation. Proc Natl Acad Sci 107:19356–19361. https://doi.org/10.1073/pnas.0914888107
Nagy E, Maquat LE (1998) A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance. Trends Biochem Sci 23:198–199. https://doi.org/10.1016/S0968-0004(98)01208-0
Papaioannou V (2014) The T-box gene family: emerging roles in development, stem cells and cancer. Development 141:3819–3833. https://doi.org/10.1242/dev.104471
Patterson J, Coats C, Mcgowan R (2020) Familial dilated cardiomyopathy associated with pathogenic TBX5 variants: expanding the cardiac phenotype associated with Holt–Oram syndrome. Am J Med Genet 182:1725–1734. https://doi.org/10.1002/ajmg.a.61635
Plageman TF, Yutzey KE (2006) Microarray analysis of Tbx5-induced genes expressed in the developing heart. Dev Dyn 235:2868–2880. https://doi.org/10.1002/dvdy.20923
Porto MPR, Vergani N, Carvalho ACC, Cernach MCSP, Brunoni D, Perez ABA (2010) Novel mutations in the TBX5 gene in patients with Holt–Oram Syndrome. Genet Mol Biol 33:232–236. https://doi.org/10.1590/S1415-47572010005000051
Ross SB, Bagnall RD, Yeates L, Sy RW, Semsarian C (2018) Holt-Oram syndrome in two families diagnosed with left ventricular noncompaction and conduction disease. Hear Rhythm Case Reports 4:146–151. https://doi.org/10.1016/j.hrcr.2017.12.002
Sabherwal N, Schneider KU, Blaschke RJ, Marchini A, Rappold G (2004) Impairment of SHOX nuclear localization as a cause for Léri-Weill syndrome. J Cell Sci 117:3041–3048. https://doi.org/10.1242/jcs.01152
Slavotinek A, Biesecker LG (2003) Genetic modifiers in human development and malformation syndromes, including chaperone proteins. Hum Mol Genet 12:45–50. https://doi.org/10.1093/hmg/ddg099
Song W, Wang H, Wu Q (2015) Atrial natriuretic peptide in cardiovascular biology and disease (NPPA). Gene 569:1–6. https://doi.org/10.1016/j.gene.2015.06.029.Atrial
Steimle JD, Moskowitz IP (2017) TBX5: a key regulator of heart development. Curr Top Dev Biol 122:195–221. https://doi.org/10.1016/bs.ctdb.2016.08.008.TBX5
Stirnimann CU, Ptchelkine D, Grimm C, Müller CW (2010) Structural basis of TBX5-DNA recognition: the T-box domain in its DNA-bound and -unbound form. J Mol Biol 400:71–81. https://doi.org/10.1016/j.jmb.2010.04.052
Vanlerberghe C, Jourdain A, Ghoumid J, Frenois F, Mezel A, Vaksmann G, Lenne B, Delobel B, Porchet N, Cormier-daire V, Smol T, Escande F, Manouvrier-hanu S, Petit F (2019) Holt-Oram syndrome: clinical and molecular description of 78 patients with TBX5 variants. Eur J Hum Genet 27:360–368. https://doi.org/10.1038/s41431-018-0303-3
Wang ZC, Ji WH, Ruan CW, Liu XY, Qiu XB, Yuan F, Li RG, Xu YJ, Liu X, Huang RT, Xue S, Yang YQ (2016) Prevalence and spectrum of TBX5 mutation in patients with lone atrial fibrillation. Int J Med Sci 13:60–67. https://doi.org/10.7150/ijms.13264
Yamak A, Georges RO, Sheikh-Hassani M, Morin M, Komati H, Nemer M (2015) Novel exons in the Tbx5 gene locus generate protein isoforms with distinct expression domains and function. J Biol Chem 290:6844–6856. https://doi.org/10.1074/jbc.M114.634451
Zaragoza MV, Lewis LE, Sun G, Wang E, Li L, Said-Salman I, Feucht L, Huang T (2004) Identification of the TBX5 transactivating domain and the nuclear localization signal. Gene 330:9–18. https://doi.org/10.1016/j.gene.2004.01.017
Zhang XL, Qiu XB, Yuan F, Wang J, Zhao CM, Li RG, Xu L, Xu YJ, Shi HY, Hou XM, Qu XK, Xu YW, Yang YQ (2015) TBX5 loss-of-function mutation contributes to familial dilated cardiomyopathy. Biochem Biophys Res Commun 459:166–171. https://doi.org/10.1016/j.bbrc.2015.02.094
Zhou W, Zhao L, Jiang JQ, Jiang WF, Yang YQ, Qiu XB (2015) A novel TBX5 loss-of-function mutation associated with sporadic dilated cardiomyopathy. Int J Mol Med 36:282–288. https://doi.org/10.3892/ijmm.2015.2206
Zhu T, Qiao L, Wang Q, Mi R, Chen J, Lu Y, Gu J, Zheng Q (2017) T-box family of transcription factor-TBX5, insights in development and disease. Am J Transl Res 9:442–453
Acknowledgements
This study received national funds from Foundation for Science and Technology (FCT) through the project UIDB/04326/2020 (CCMAR). DV and TV are supported by FCT doctoral fellowships (Grant number: SFRH/BD/141918/2018 and SFRH/BD/144230/2019, respectively). The authors are grateful to the individuals enrolled in this study and to Dr. Qing Wang for providing the pcDNA3.1-His6-TBX5 construct.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interests
The authors declare no competing interests.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Communicated by Stefan Hohmann.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Varela, D., Varela, T., Conceição, N. et al. Functional analysis of two novel TBX5 variants present in individuals with Holt–Oram syndrome with different clinical manifestations. Mol Genet Genomics 296, 809–821 (2021). https://doi.org/10.1007/s00438-021-01781-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00438-021-01781-2